From November 20, 2023 to December 31, 2023, the company has repurchased 7,201,500 shares, representing 1.35% for CNY 95.84 million. With this, the company has completed the repurchase of 7,201,500 shares, representing 1.35% for CNY 95.84 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.09 CNY | +1.20% | +6.77% | -24.87% |
04-24 | ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-24 | ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.87% | 708M | |
-3.39% | 266B | |
-2.66% | 95.09B | |
-2.95% | 43.48B | |
+1.09% | 40.63B | |
+6.94% | 40.07B | |
+6.85% | 39.47B | |
-14.36% | 30.45B | |
-4.55% | 28.98B | |
+14.11% | 25.18B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.